Loading…

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus

Success in delivering value-based healthcare involves measuring outcomes that matter most to patients. Our aim was to develop a minimum Standard Set of patient-centred outcome measures for inflammatory bowel disease [IBD], for use in different healthcare settings. An international working group [n =...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2018-03, Vol.12 (4), p.408-418
Main Authors: Kim, Andrew H, Roberts, Charlotte, Feagan, Brian G, Banerjee, Rupa, Bemelman, Willem, Bodger, Keith, Derieppe, Marc, Dignass, Axel, Driscoll, Richard, Fitzpatrick, Ray, Gaarentstroom-Lunt, Janette, Higgins, Peter D, Kotze, Paulo Gustavo, Meissner, Jillian, O'Connor, Marian, Ran, Zhi-Hua, Siegel, Corey A, Terry, Helen, van Deen, Welmoed K, van der Woude, C Janneke, Weaver, Alandra, Yang, Suk-Kyun, Sands, Bruce E, Vermeire, Séverine, Travis, Simon Pl
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Success in delivering value-based healthcare involves measuring outcomes that matter most to patients. Our aim was to develop a minimum Standard Set of patient-centred outcome measures for inflammatory bowel disease [IBD], for use in different healthcare settings. An international working group [n = 25] representing patients, patient associations, gastroenterologists, surgeons, specialist nurses, IBD registries and patient-reported outcome measure [PROM] methodologists participated in a series of teleconferences incorporating a modified Delphi process. Systematic review of existing literature, registry data, patient focus groups and open review periods were used to reach consensus on a minimum set of standard outcome measures and risk adjustment variables. Similar methodology has been used in 21 other disease areas [www.ichom.org]. A minimum Standard Set of outcomes was developed for patients [aged ≥16] with IBD. Outcome domains included survival and disease control [survival, disease activity/remission, colorectal cancer, anaemia], disutility of care [treatment-related complications], healthcare utilization [IBD-related admissions, emergency room visits] and patient-reported outcomes [including quality of life, nutritional status and impact of fistulae] measured at baseline and at 6 or 12 month intervals. A single PROM [IBD-Control questionnaire] was recommended in the Standard Set and minimum risk adjustment data collected at baseline and annually were included: demographics, basic clinical information and treatment factors. A Standard Set of outcome measures for IBD has been developed based on evidence, patient input and specialist consensus. It provides an international template for meaningful, comparable and easy-to-interpret measures as a step towards achieving value-based healthcare in IBD.
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjx161